March is National Colorectal Cancer Awareness Month, a time to come together to raise awareness about the importance of early detection and prevention of colorectal cancer. This month presents an opportunity to promote and market the offerings of BioReference Health in the field of colorectal cancer care. At BioReference, we are dedicated to advancing oncology […]
Search Results for: NEW
21
Feb
Feb
Clinical testing and genomic insights have revolutionized the way disease is understood, which has enabled personalized treatment approaches that can be tailored to an individual’s unique genetic makeup. Harnessing the potential of genomic testing and its cutting-edge technology can significantly benefit patient outcomes. Read on to learn how BioReference® is supporting genomic testing and clinical […]
Blog
The Power of Data Integration: Transforming Oncology Outcomes with Clinical and Genomic Insights
07
Dec
Dec
In the world of healthcare, data has become essential to driving better patient outcomes. From clinical records to genomic insights, the convergence of various data sources is revolutionizing research and development (R&D) in pharmaceutical companies. In this article, we will explore the remarkable potential of real-world data (RWD), particularly in oncology, and how its integration […]
Press Release
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
28
Nov
Nov
Elmwood Park, NJ – November 28, 2023 – BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data (“RWD”) for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions […]
27
Nov
Nov
Lung and bronchus cancer represents more than one eighth of all new cancer cases in the US and is the leading cause of cancer deaths worldwide, according to the World Health Organization. As we wrap up on National Lung Cancer Awareness Month this November, we aim to empower patients to take more control of their […]
Press Release
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
07
Nov
Nov
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON, MA, ELMWOOD PARK, NJ, and Rolle, Switzerland, November 7, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that […]
26
Oct
Oct
According to the National Down syndrome Society, in the US, 1 in 772 live births result in a Down syndrome diagnosis, making Down syndrome the most common chromosomal condition. The month of October is Down Syndrome Awareness Month, giving families, individuals, and patients the opportunity to share information about the condition, learn more, and contribute […]
23
Oct
Oct
It’s October and Breast Cancer Awareness Month! Remember to monitor your breast health and speak to your healthcare provider about screenings including genetic testing for hereditary breast cancer.
09
May
May
National Women’s Health Week is an annual initiative driven by the U.S. Department of Health and Human Services that aims to raise awareness and encourage women to make their health a priority. While finding the time and resources to properly manage one’s health may feel overwhelming, there are many actionable ways women can take to […]
24
Apr
Apr
Each year, the last week of April brings a special time to recognize the dedicated individuals at the core of BioReference – our Laboratory Professionals. Since 1975, Medical Laboratory Professionals Week has been observed by the American Society of Laboratory Science (ASCLS) and 17 other national organizations, as an annual celebration recognizing the contributions of […]
